MERCK KGAA NAM.SP.ADR 1/5

MERCK KGAA NAM.SP.ADR 1/5 Depository Receipt · US5893392093 · A2DUS5 (PINX) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MERCK KGAA NAM.SP.ADR 1/5
No Price
01.05.2026 19:56
Current Prices from MERCK KGAA NAM.SP.ADR 1/5
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
MKKGY
USD
01.05.2026 19:50
25,87 USD
-0,03 USD
-0,12 %
XDUS: Düsseldorf
Düsseldorf
MKGANA93.DUSB
EUR
30.04.2026 17:30
21,40 EUR
-
XDQU: Quotrix
Quotrix
MKGANA93.DUSD
EUR
30.04.2026 05:27
21,60 EUR
-
Company Profile for MERCK KGAA NAM.SP.ADR 1/5 Depository Receipt
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment also provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. The Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Company Data

Name MERCK KGAA NAM.SP.ADR 1/5
Company Merck KGaA
Website https://www.merckgroup.com/en
Primary Exchange PINX OTC PINK MARKETPLACE
WKN A2DUS5
ISIN US5893392093
Asset Class Depository Receipt
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Belen Garijo Lopez
Market Capitalization 56 Mrd.
Country Germany
Currency EUR
Employees 59,0 T
Address Frankfurter Strasse 250, 64293 Darmstadt
IPO Date 2007-11-16
Dividends from 'MERCK KGAA NAM.SP.ADR 1/5'
Ex-Date Dividend per Share
28.04.2026 0,34 USD
29.04.2025 0,50 USD
29.04.2024 0,47 USD
02.05.2023 0,47 USD
25.04.2022 0,41 USD
26.04.2021 0,33 USD
01.06.2020 0,19 USD
29.04.2019 0,19 USD
01.05.2018 0,21 USD
01.05.2017 0,44 USD

Stock Splits

Date Split
15.08.2017 833:500
11.07.2014 2:1
30.06.2014 2:1

Ticker Symbols

Name Symbol
Over The Counter MKKGY
Düsseldorf MKGANA93.DUSB
Frankfurt MRKC.F
Quotrix MKGANA93.DUSD
More Shares
Investors who hold MERCK KGAA NAM.SP.ADR 1/5 also have the following shares in their portfolio:
DZ BANK CLN E.10458
DZ BANK CLN E.10458 Bond
Gold Rock Holdings, Inc.
Gold Rock Holdings, Inc. Share